Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton’s tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics

Tirabrutinib is a highly selective Bruton’s tyrosine kinase (BTK) inhibitor used to treat hematological malignancies. We analyzed the anti-tumor mechanism of tirabrutinib using phosphoproteomic and transcriptomic methods. It is important to check the drug’s selectivity against off-target proteins to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozaki, Ryohei, Yasuhiro, Tomoko, Kato, Hikaru, Murai, Jun, Hotta, Shingo, Ariza, Yuko, Sakai, Shunsuke, Fujikawa, Ryu, Yoshida, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004634/
https://www.ncbi.nlm.nih.gov/pubmed/36897912
http://dx.doi.org/10.1371/journal.pone.0282166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004634/
https://www.ncbi.nlm.nih.gov/pubmed/36897912
http://dx.doi.org/10.1371/journal.pone.0282166

Ejemplares similares